DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Capillary Technologies India Limited — Price movement

NSE 2 hrs ago·25 Sept 2026, 3:18 pm

Capillary Techno India L

Capillary Technologies India Limited saw a significant movement in its share price, prompting the stock exchange to write to the company. The exchange requested an explanation to ensure investors have accurate information and to safeguard market interests. In response, the company has submitted a detailed explanation regarding the price movement.

This development is important for investors as it signals that the market is actively monitoring the stock for any material information. The company's response will clarify the reasons behind the volatility, helping investors better understand the current situation. It is a standard regulatory step to maintain transparency in the market.

Investors should wait for the company's official response to understand the full context. Monitoring the stock's future performance and any further regulatory updates will be key to gauging the impact of this event on the company's valuation.